Prime Results Funding: How Much Did They Raise & Key Investors

How Much Did Prime Results Raise?
Funding & Key Investors

Prime Results has successfully secured a significant capital injection, bringing its total funding to $316K. This latest infusion of $166K represents a major strategic investment aimed at bolstering the company's market position within the high-stakes pharmaceutical manufacturing sector. By leveraging this debt-based financing, the firm is well-positioned to accelerate its growth trajectory and expand its footprint in the specialized field of automated inspection technology.

The company's financial history reflects a consistent pattern of growth, starting with an initial debt financing round in April 2020, followed by the most recent capital deployment in March 2021. This progression underscores the firm's ability to attract institutional support as it scales its complex, high-precision solutions for global pharmaceutical clients.

What is Prime Results?

Prime Results

Business Services

Software Testing

Project Management

Prime Results operates at the intersection of industrial automation and pharmaceutical quality assurance. The company provides a suite of sophisticated tools, including the AIME program for component tracking and the CRIS system for automated inspection of small-batch products. By offering qualification services and USP 1790-compliant defect test sets, Prime Results enables manufacturers to maintain rigorous quality standards while simultaneously driving operational efficiency. Their market position is defined by a deep integration into the quality systems of pharmaceutical producers, where precision and compliance are paramount. Through its focus on process improvement and vision inspection, the company serves as a critical partner for firms navigating the complexities of modern drug manufacturing and regulatory oversight.

How much funding has Prime Results raised?

Prime Results has raised a total of $316K across 2 funding rounds:

2020

Debt

$150K

2021

Debt

$166K

Debt (2020): $150K with participation from PPP

Debt (2021): $166K led by PPP

Key Investors in Prime Results

PPP

Public-Private Partnership

What's next for Prime Results?

With this latest round of financing, Prime Results is poised to transition into a phase of intensified market penetration and technological refinement. The company is expected to utilize these resources to scale its CRIS and AIME platforms, potentially expanding its reach into new geographic markets or diversifying its service offerings to address emerging challenges in pharmaceutical inspection. As the industry continues to shift toward fully automated, data-driven quality control, Prime Results is strategically aligned to capitalize on the increasing demand for reliable, compliant, and efficient inspection infrastructure. Future growth will likely center on enhancing the interoperability of their systems with existing manufacturing execution platforms, further cementing their role as an essential component of the pharmaceutical supply chain.

See full Prime Results company page

See More Financial Insights